Financhill
Buy
76

DBD Quote, Financials, Valuation and Earnings

Last price:
$64.64
Seasonality move :
11.65%
Day range:
$64.46 - $67.00
52-week range:
$34.88 - $67.00
Dividend yield:
0%
P/E ratio:
47.42x
P/S ratio:
0.66x
P/B ratio:
2.10x
Volume:
472K
Avg. volume:
207.4K
1-year change:
38.4%
Market cap:
$2.3B
Revenue:
$3.8B
EPS (TTM):
$1.36

Analysts' Opinion

  • Consensus Rating
    Diebold Nixdorf, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $79.00, Diebold Nixdorf, Inc. has an estimated upside of 22.1% from its current price of $64.70.
  • Price Target Downside
    According to analysts, the lowest downside price target is $77.00 representing 100% downside risk from its current price of $64.70.

Fair Value

  • According to the consensus of 2 analysts, Diebold Nixdorf, Inc. has 22.1% upside to fair value with a price target of $79.00 per share.

DBD vs. S&P 500

  • Over the past 5 trading days, Diebold Nixdorf, Inc. has underperformed the S&P 500 by -0.06% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Diebold Nixdorf, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Diebold Nixdorf, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Diebold Nixdorf, Inc. reported revenues of $945.2M.

Earnings Growth

  • Diebold Nixdorf, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Diebold Nixdorf, Inc. reported earnings per share of $1.11.
Enterprise value:
3.1B
EV / Invested capital:
1.43x
Price / LTM sales:
0.66x
EV / EBIT:
11.30x
EV / Revenue:
0.84x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
13.57x
Price / Operating cash flow:
10.55x
Enterprise value / EBITDA:
7.58x
Gross Profit (TTM):
$940.2M
Return On Assets:
1.44%
Net Income Margin (TTM):
1.44%
Return On Equity:
5.1%
Return On Invested Capital:
2.52%
Operating Margin:
9.15%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $3.7B $5B $3.7B $927.1M $945.2M
Gross Profit $872.2M $2.1B $940.2M $241.8M $247.9M
Operating Income $108.6M $1.5B $275.5M $79.7M $86.5M
EBITDA $237.8M $1.6B $410.5M $110.3M $118.2M
Diluted EPS $45.27 $0.00 $1.36 -$0.60 $1.11
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $1.9B $1.7B $2.1B $1.9B $1.7B
Total Assets $3.6B $2.9B $4B $3.9B $3.7B
Current Liabilities $1.6B $3.9B $1.4B $1.3B $1.3B
Total Liabilities $4.5B $4.2B $3B $2.8B $2.6B
Total Equity -$863.5M -$1.3B $991.5M $1.1B $1.1B
Total Debt $2.5B $2.4B $1.3B $1.1B $1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$324.7M $115.6M $279.4M -$15.5M $37.4M
Cash From Investing -$49.3M -$38M -$76.3M -$12.4M -$26.2M
Cash From Financing $682.6M -$181.3M -$280.2M -$4.6M -$44.1M
Free Cash Flow -$399.4M $72.8M $229.5M -$24.9M $24.5M
DBD
Sector
Market Cap
$2.3B
$54.4M
Price % of 52-Week High
96.57%
59.37%
Dividend Yield
0%
0%
Shareholder Yield
0.32%
0.01%
1-Year Price Total Return
38.4%
-11.77%
Beta (5-Year)
--
0.674
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $64.82
200-day SMA
Buy
Level $53.49
Bollinger Bands (100)
Buy
Level 56.92 - 62.78
Chaikin Money Flow
Buy
Level 9.3M
20-day SMA
Buy
Level $64.07
Relative Strength Index (RSI14)
Buy
Level 56.66
ADX Line
Buy
Level 14.49
Williams %R
Neutral
Level -31.768
50-day SMA
Buy
Level $60.17
MACD (12, 26)
Buy
Level 1.38
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 14.2M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.8341)
Sell
CA Score (Annual)
Level (-0.8545)
Buy
Beneish M-Score (Annual)
Level (-2.8569)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-48.6393)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Diebold Nixdorf, Inc. engages in the provision of integrated software-led services, self-service delivery and security systems to financial, retail, commercial, and government markets. It offers financial self-services such as self-service support and maintenance, value-added services, self-service software, and self-service products, and security solutions including physical and electronic security. It operates through the following segments: Eurasia Banking, Americas Banking, and Retail. The company was founded in 1859 and is headquartered North Canton, OH.

Stock Forecast FAQ

In the current month, DBD has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DBD average analyst price target in the past 3 months is $79.00.

  • Where Will Diebold Nixdorf, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Diebold Nixdorf, Inc. share price will rise to $79.00 per share over the next 12 months.

  • What Do Analysts Say About Diebold Nixdorf, Inc.?

    Analysts are divided on their view about Diebold Nixdorf, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Diebold Nixdorf, Inc. is a Sell and believe this share price will drop from its current level to $77.00.

  • What Is Diebold Nixdorf, Inc.'s Price Target?

    The price target for Diebold Nixdorf, Inc. over the next 1-year time period is forecast to be $79.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is DBD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Diebold Nixdorf, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of DBD?

    You can purchase shares of Diebold Nixdorf, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Diebold Nixdorf, Inc. shares.

  • What Is The Diebold Nixdorf, Inc. Share Price Today?

    Diebold Nixdorf, Inc. was last trading at $64.64 per share. This represents the most recent stock quote for Diebold Nixdorf, Inc.. Yesterday, Diebold Nixdorf, Inc. closed at $64.70 per share.

  • How To Buy Diebold Nixdorf, Inc. Stock Online?

    In order to purchase Diebold Nixdorf, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 144.68% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is up 1.27% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock